including syndromic real-time PCR and an automated product development system (SGDDS), with a leading company partnered in ...

The global PD-L1 biomarker testing market is experiencing remarkable growth, fueled by the increasing demand for personalized ...

Telix Pharmaceuticals’ brain cancer diagnostic could leapfrog over its kidney cancer assay to be its second commercialised ...

BlueMark, a leading independent impact verification and intelligence provider for the impact and sustainable investing markets, today introduced a new rating system for impact investors called the ...

In its ongoing commitment to raise awareness about chronic health issues, Metropolis Healthcare Limited, one of India’s ...

Q3 2024 Earnings Call Transcript October 22, 2024 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

The global self-testing market is on the verge of substantial expansion, with Future Market Insights (FMI) forecasting a rise ...

Mechelen, Belgium, 23 October 2024 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that six ... potentially due to a higher sensitivity than the ...

According to a new study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford ...

Voters are gearing up to voice their choice.  If Ballot Question Two passes, students will no longer have to pass the ...